As filed with the Securities and Exchange Commission on August 11, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Agenus Inc.
(Exact name of registrant as specified in its charter)
Delaware | 06-1562417 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
3 Forbes Road, Lexington, MA 02421
(Address of principal executive offices, including zip code)
AGENUS INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN
AGENUS INC. 2019 EMPLOYEE STOCK PURCHASE PLAN
AGENUS INC. AMENDED AND RESTATED DIRECTORS DEFERRED COMPENSATION PLAN
(Full title of the plan)
Garo H. Armen, Ph.D.
Agenus Inc.
3 Forbes Road
Lexington, MA 02421
781-674-4400
(Name, address and telephone number, including area code, of agent for service)
Please send copies of all communications to:
Zachary Blume
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, MA 02199-3600
(617) 951-7000
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
Explanatory Note
This registration statement on Form S-8 is being filed by Agenus Inc. (the Registrant) for the purpose of registering shares of the Registrants common stock, $0.01 par value per share (Common Stock) issuable under (i) the Registrants Amended and Restated 2019 Equity Incentive Plan (the 2019 Plan), (ii) the Registrants 2019 Employee Stock Purchase Plan (the ESPP) and (iii) the Registrants Amended and Restated Directors Deferred Compensation Plan (the DDCP).
The Registrants stockholders approved amendments to (x) the 2019 Plan to increase the number of shares of Common Stock issuable pursuant to the 2019 Plan at each of the Registrants Annual Meeting of Stockholders on June 15, 2021 (the 2021 Annual Meeting) and the Annual Meeting of Stockholders on June 8, 2022 (the 2022 Annual Meeting), (y) the ESPP to increase the number of shares issuable pursuant to the ESPP at the 2021 Annual Meeting; and (z) the DDCP to increase the number of shares issuable pursuant to the DDCP at the Registrants Annual Meeting of Stockholders on June 16, 2020 and the 2022 Annual Meeting.
Pursuant to General Instruction E to Form S-8, this registration statement incorporates by reference the contents of the registration statements on Form S-8, File Nos. 333-233100, 333-233097, 333-228271, 333-209074, 333-183067, 333-176609, 333-160088, 333-143807 and 333-106072, filed by the Registrant on August 7, 2019, August 7, 2019, November 8, 2018, January 21, 2016, August 3, 2012, September 1, 2011, June 19, 2009, June 15, 2007 and June 12, 2003, respectively, relating to the 2019 Plan, the ESPP and the DDCP.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8 | Exhibits. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Lexington, Commonwealth of Massachusetts, on this 11th day of August, 2022.
AGENUS INC. | ||
By: | /s/ Garo H. Armen, Ph.D. | |
Garo H. Armen, Ph.D. | ||
Chief Executive Officer and Chairman of the Board |
We, the undersigned officers and directors of Agenus Inc., hereby severally constitute and appoint Garo Armen and Christine M. Klaskin, and each of them singly, our true and lawful attorneys-in-fact, with full power to them in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including any post-effective amendments thereto), and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated below on the dates indicated.
SIGNATURE |
TITLE |
DATE | ||
/s/ Garo H. Armen, Ph.D. |
Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) |
August 11, 2022 | ||
Garo H. Armen, Ph.D. | ||||
/s/ Christine M. Klaskin |
Vice President, Finance (Principal Financial and Accounting Officer) |
August 11, 2022 | ||
Christine M. Klaskin | ||||
/s/ Brian Corvese |
Director | August 11, 2022 | ||
Brian Corvese | ||||
/s/ Allison Jeynes-Ellis |
Director | August 11, 2022 | ||
Allison Jeynes-Ellis | ||||
/s/ Wadih Jordan |
Director | August 11, 2022 | ||
Wadih Jordan | ||||
/s/ Ulf Wiinberg |
Director | August 11, 2022 | ||
Ulf Wiinberg | ||||
/s/ Timothy R. Wright |
Director | August 11, 2022 | ||
Timothy R. Wright | ||||
/s/ Susan Hirsch |
Director | August 11, 2022 | ||
Susan Hirsch |
![]() |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM |
Exhibit 5.1 |
August 11, 2022
Agenus Inc.
3 Forbes Road
Lexington, MA 02421
Re: Registration of Securities by Agenus Inc.
Ladies and Gentlemen:
We have acted as counsel to Agenus Inc., a Delaware corporation (the Company), in connection with the registration statement on Form S-8 (the Registration Statement) filed by the Company on the date hereof with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), for the registration of 26,220,688 shares of Common Stock, $0.01 par value, of the Company (the Shares). 25,775,420 of the Shares are issuable under the Companys 2019 Equity Incentive Plan (the 2019 EIP), 95,268 of the Shares are issuable under the Companys 2019 Employee Stock Purchase Plan (the 2019 ESPP) and 350,000 of the Shares are issuable under the Companys Amended and Restated Directors Deferred Compensation Plan (together with the 2019 EIP and the 2019 ESPP, the Plans).
We are familiar with the actions taken by the Company in connection with the adoption of the Plans. We have examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent verification, upon certificates of officers of the Company, public officials and other appropriate persons.
The opinions expressed below are limited to the Delaware General Corporation Law.
Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized and, when the Shares have been issued and sold in accordance with the terms of the Plan, the Shares will be validly issued, fully paid and non-assessable.
We hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.
Very truly yours, |
/s/ Ropes & Gray LLP |
Ropes & Gray LLP |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated March 1, 2022, with respect to the consolidated financial statements of Agenus Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.
/s/ KPMG LLP
Boston, Massachusetts
August 11, 2022
Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Agenus Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule |
Amount Registered (1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee | |||||||
Equity | Common stock, $0.01 par value per share | Rules 457(c) and 457(h) | 12,555,583(2) | $3.23(3) | $40,554,533 | 0.0000927 | $3,759 | |||||||
Equity | Common stock, $0.01 par value per share | Rules 457(c) and 457(h) | 13,219,837(4) | $2.52(5) | $33,313,989 | 0.0000927 | $3,088 | |||||||
Equity | Common stock, $0.01 par value per share | Rules 457(c) and 457(h) | 95,268(6) | $2.52(5) | $240,075 | 0.0000927 | $22 | |||||||
Equity | Common stock, $0.01 par value per share | Rules 457(c) and 457(h) | 350,000(7) | $2.52(5) | $882,000 | 0.0000927 | $82 | |||||||
Total Offering Amounts | $74,990,598 | $6,952 | ||||||||||||
Total Fee Offsets (8) | | |||||||||||||
Net Fee Due | $6,952 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this registration statement on Form S-8 (Registration Statement) shall also cover any additional shares of the common stock of Agenus Inc. (the Registrant) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrants receipt of consideration that results in an increase in the number of the outstanding shares of the Registrants common stock. |
(2) | Represents shares of Common Stock reserved for issuance upon exercise or settlement of awards pursuant to under the Registrants Amended and Restated 2019 Equity Incentive Plan (the EIP) and that are outstanding as of the date of this Registration Statement. |
(3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act of 1933. For the shares of Common Stock reserved for issuance upon the exercise of outstanding awards granted under the EIP, the Proposed Maximum Offering Price Per Unit is $3.23, which is the weighted average exercise price (rounded to the nearest cent) of the outstanding awards under the EIP. |
(4) | Represents shares of Common Stock reserved for issuance under the EIP. |
(5) | Estimated solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and Rule 457(h) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are calculated on the basis of the average of the high ($2.66) and low ($2.37) sale prices per share of the common stock on the Nasdaq Capital Market as of August 9, 2022, which is a date within five business days prior to filing this Registration Statement. |
(6) | Represents shares of Common Stock reserved for issuance under the Registrants 2019 Employee Stock Purchase Plan (the ESPP). |
(7) | Represents shares of Common Stock reserved for issuance under the Registrants Amended and Restated Directors Deferred Compensation Plan (the DDCP). |
(8) | The Registrant does not have any fee off-sets. |